Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up

K Dahan, H Debiec, E Plaisier… - Journal of the …, 2017 - journals.lww.com
Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been
conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals …
被引用次数：410 相关文章

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

K Dahan, H Debiec, E Plaisier… - Journal of the …, 2017 - hal-emse.ccsd.cnrs.fr
Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been
conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals …

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

K Dahan, H Debiec, E Plaisier… - Journal of the …, 2017 - u-picardie.hal.science
Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been
conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals …

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

K Dahan, H Debiec, E Plaisier… - Journal of the …, 2017 - hal.univ-smb.fr
Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been
conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals …

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

K Dahan, H Debiec, E Plaisier, M Cachanado… - Journal of the American …, 2017 - hal.science
Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been
conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals …

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

K Dahan, H Debiec, E Plaisier… - Journal of the …, 2017 - hal-ciheam.iamm.fr
Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been
conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals …

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

K Dahan, H Debiec, E Plaisier… - Journal of the …, 2017 - univ-rennes.hal.science
Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been
conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals …

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.

K Dahan, H Debiec, E Plaisier… - Journal of the …, 2016 - europepmc.org
Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been
conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals …

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

K Dahan, H Debiec, E Plaisier… - Journal of the …, 2017 - inria.hal.science
Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been
conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals …
[PDF] researchgate.net

[PDF][PDF] Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

K Dahan, H Debiec, E Plaisier, M Cachanado… - 2016 - researchgate.net
Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been
conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals …